Pfizer and Allergan to Combine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Pfizer (PFE) And Allergan (AGN) Could Trade 'Range-Bound', Says Deutsche Bank
November 23, 2015 1:57 PM ESTShares of Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) could be 'range-bound' for some time, according to Deutsche Bank analyst Gregg Gilbert. Comments follow news the two companies reached a $160 billion merger agreement.
"Conceptually, we could see both stocks remaining range-bound for some time (close expected in 2H16) as investors of various types consider the merits of the transaction," said Gilbert."This deal, if closed, will make PFE an... More
